Protara Therapeutics, Inc. (TARA) Debt Components
- 2021-12-31: Short-term DebtUSD (m); Convertible Notes Payable, CurrentUSD (m); Debt, CurrentUSD $0.00; Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2020-12-31: Short-term DebtUSD (m); Convertible Notes Payable, CurrentUSD (m); Debt, CurrentUSD $0.00; Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2020-09-30: Short-term DebtUSD $370.79K; Convertible Notes Payable, CurrentUSD (m); Debt, CurrentUSD $370.79K; Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2020-06-30: Short-term DebtUSD $926.98K; Convertible Notes Payable, CurrentUSD (m); Debt, CurrentUSD $926.98K; Debt Instrument, Interest Rate, Stated Percentagepure (m).
Protara Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Convertible Notes Payable, Current USD | Debt, Current USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Convertible, Conversion Ratio pure | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2020-09-30 | $370.79K | (m) | $370.79K | (m) | (m) | (m) | (m) |
| 2020-06-30 | $926.98K | (m) | $926.98K | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.30M | (m) | $1.30M | (m) | (m) | (m) | (m) |
| 2020-01-09 | (m) | (m) | (m) | (m) | 19.08% | (m) | (m) |
| 2013-12-31 | (m) | $3.73M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-04 | (m) | (m) | (m) | 8.00% | (m) | (m) | (m) |
| 2013-09-04 | (m) | (m) | (m) | (m) | (m) | $7.00M | $1.40M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |